Levofloxacin pharmacokinetics/pharmacodynamics, dosing, susceptibility breakpoints, and artificial intelligence in the treatment of multidrug-resistant tuberculosis
<p><strong>Background</strong> Levofloxacin is used for the treatment of multidrug-resistant tuberculosis; however the optimal dose is unknown.</p> <p><strong>Methods</strong> We used the hollow fiber system model of tuberculosis (HFS-TB) to identify 0–24 h...
Hoofdauteurs: | Deshpande, D, Pasipanodya, JG, Mpagama, SG, Bendet, P, Srivastava, S, Koeuth, T, Lee, PS, Bhavnani, SM, Ambrose, PG, Thwaites, G, Heysell, SK, Gumbo, T |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
Oxford University Press
2018
|
Onderwerpen: |
Gelijkaardige items
-
Wild-Type MIC Distribution for Re-evaluating the Critical Concentration of Anti-TB Drugs and Pharmacodynamics Among Tuberculosis Patients From South India
door: Azger Dusthackeer, et al.
Gepubliceerd in: (2020-06-01) -
Efflux-mediated resistance identified among norfloxacin resistant clinical strains of group B from South Korea
door: Trang Nguyen Doan Dang, et al.
Gepubliceerd in: (2014-10-01) -
Discordance in genotypic and phenotypic drug susceptibility results: time to reconsider critical concentration of rifampicin
door: Arti Shrivas, et al.
Gepubliceerd in: (2025-03-01) -
Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors
door: Manoj Chandran, et al.
Gepubliceerd in: (2015-01-01) -
Novel oxazolidinones harbor potent in vitro activity against the clinical isolates of multidrug-resistant Mycobacterium tuberculosis in China
door: Chenqian Wang, et al.
Gepubliceerd in: (2022-11-01)